title: Biogen, Serono squabble over MS market.
authors.affiliation: Brighton, UK.
authors.forename: S
authors.initials: S
authors.lastname: Davidson
mesh_terms: D002986:Clinical Trials as Topic; D004345:Drug Industry / Q000331:legislation & jurisprudence* / Q000639:trends*; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016899:Interferon-beta; D000068556:Interferon beta-1a